The latest report from the WHO and Unicef found cases have increased nearly 80% worldwide.
Existing coronavirus vaccines are not as effective against newer variants of the virus. Two vaccine experts explain how new vaccines currently in development...
Five oil refiner investments to buy provide a gusher of opportunities as the sector embarks upon what BofA Global Securities calls a new “golden age,”...
In March, CordenPharma was listed among the pharma giants picked by the German government as recipients of more than $3 billion to ensure that the country...
Covid-19 vaccine manufacturers, the FDA, CDC, and vaccine experts will need to come together and make a decision within the next month on who should be...
As reported in 2021, autistic adults, adults with intellectual disability and adults with mental health diagnoses have multiple risk factors for COVID-19...
Alain Labrique, PhD, professor and associate chair of research at Johns Hopkins Bloomberg School of Public Health (JHSPH) The post Studying inequities...
Gilead recently collected its 5th priority review voucher, this time for its megablockbuster Covid-19 drug remdesivir, which brought in $1.5 billion last...
LIVE PRESS EVENT: Join Dr. Tobin for a Q & A on this paper at 1:00 p.m. ET on April 28. Register now. Credit: ATS LIVE...
In spite of all the chaos 2021 unleashed on the world, it was another incredible year of growth and innovation at FCB Health NY, according to...
Gilead recently collected its 5th priority review voucher, this time for its megablockbuster Covid-19 drug remdesivir, which brought in $1.5 billion last...
Moderna Inc.'s chief medical officer said on Sunday the company's vaccine for children under 6 years old will be ready for review by a Food and...
Bill Haney’s Dragonfly Therapeutics is making the vault between biotech startup and the next big level: adding clinical-stage compounds to its own fledgling...
How might one gauge the contributions of selected geographical regions to cancer immunotherapy? Initially, one might assess cancer incidence and prevalence...
In the vaccine industry, as well as in the broader pharmaceutical industry, expectations for mRNA technology used to be fairly modest. But all that changed...
Stock index futures gain ground going into key economic policy updates from the central bank. The post Top Stock Market News For Today May 2, 2022...
A recently named sub-strain represents the latest twist in the ongoing evolution of SARS-CoV-2. It’s currently active in the United States and looks...
Children ages 6 months to under 6 years may soon have access to a Covid-19 vaccine that has been submitted to the FDA for emergency use...
New COVID Bill Fines Parents For Unvaxxed Kids And Doubles Income Taxes An absurd COVID-19 bill by radical leftist Road Island Senator Samuel...
Michigan Investigated Hundreds Of Doctors, Nurses Over COVID-Related Complaints Authored by Alice Giordano via The Epoch Times (emphasis ours), Hundreds...
"Not The Right Fit" - Disney Exec Who Led Anti-Florida-Bill Response Leaves Firm After 3 Months The Disney executive who sculpted the company's...
Check out these pharmaceutical stocks in the stock market today. The post Top Pharmaceutical Stocks To Watch In May 2022 appeared first on Stock Market...
Macro update Financial markets roared back to life over December, boosted by news of potential breakthroughs on multiple COVID-19 vaccine trials. The confluence...
How did getting vaccinated for Covid-19 get mixed up with freedom? I was pondering that as I read a piece in The Hill about Trump’s recent...
The pandemic is still raging. Health, money, work, relationships, environment have changed throughout the world, and perhaps permanently so.
Hundreds Of CDC Employees Still Haven't Received COVID-19 Vaccine Authored by Zachary Stieber via The Epoch Times (emphasis ours), Nearly...
Halloween is closer than you think.
AstraZeneca topped off a very busy week with the company's first-quarter 2022 financial report, citing a total of $11.39 billion in revenue, a whopping...
AstraZeneca's COVID-19 vaccine still has market potential despite an expected global oversupply of shots and delays in the vaccine's approval in the United...
Halloween is closer than you think.